Hospital Universitario Virgen Macarena-merge

Seville 41009

1 studies enrolling now · 3 studies all time

What they study most

Cutaneous Squamous Cell Carcinoma, Obstructive Hypertrophic Cardiomyopathy (oHCM), Symptomatic Hypertrophic Cardiomyopathy (HCM)

Studies at this site

• Study of Adjuvant Cemiplimab Versus Placebo After Surgery and Radiation Therapy in Patients With High Risk Cutaneous Squamous Cell Carcinoma — Running, not enrolling
• Phase 3 Trial to Evaluate the Efficacy and Safety of Aficamten Compared to Placebo in Adults With Symptomatic oHCM — Completed
• Open-label Extension Study to Evaluate the Long-term Safety and Tolerability of Aficamten in Adults With HCM — Enrolling by invitation